3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
86
Breast Neoplasms
48
Prostatic Neoplasms
43
Squamous Cell Carcinoma of Head and Neck
34
Lung Neoplasms
24
Stomach Neoplasms
18
Neoplasms
18
Head and Neck Neoplasms
17
Neoplasm Metastasis
16
Parkinson Disease 4, Autosomal Dominant Lewy Body
14
Urinary Bladder Neoplasms
13
Carcinoma, Transitional Cell
11
Triple Negative Breast Neoplasms
10
Ovarian Neoplasms
8
Endometrial Neoplasms
8
Carcinoma, Squamous Cell
8
Adenocarcinoma
8
HER2-positive Breast Cancer
7
Non-Muscle Invasive Bladder Neoplasms
6
Melanoma
6
Carcinoma
6
Small Cell Lung Carcinoma
5
Prostatic Neoplasms, Castration-Resistant
5
Nasopharyngeal Carcinoma
5
Esophageal Neoplasms
5
Uterine Cervical Neoplasms
4
Sarcoma
4
Oropharyngeal Neoplasms
4
Fallopian Tube Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Interventions
Cyclophosphamide
61
Rituximab
50
fludarabine
34
Prednisone
33
Doxorubicin
28
Biopsy
26
Vincristine
25
Specimen Handling
22
Magnetic Resonance Spectroscopy
20
Bendamustine Hydrochloride
19
pembrolizumab
16
Lenalidomide
16
obinutuzumab
14
fludarabine phosphate
14
Etoposide
14
venetoclax
13
Tacrolimus
11
Mycophenolic Acid
10
Melphalan
10
Dexamethasone
10
zanubrutinib
9
ibrutinib
9
acalabrutinib
9
Radiotherapy
9
Gemcitabine
9
Cytarabine
9
Busulfan
9
Whole-Body Irradiation
8
Mesna
8
Filgrastim
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Docetaxel
×
1 year
×
Clear all
No trials found.